APA (7th ed.) Citation

DM, P., DR, S., MS, A., CJ, B., N, A., GH, S., . . . GH, B. (2010). Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme. Journal of neuro-oncology, 98(1), 93. https://doi.org/10.1007/s11060-009-0067-2

Chicago Style (17th ed.) Citation

DM, Peereboom, et al. "Phase II Trial of Erlotinib with Temozolomide and Radiation in Patients with Newly Diagnosed Glioblastoma Multiforme." Journal of Neuro-oncology 98, no. 1 (2010): 93. https://doi.org/10.1007/s11060-009-0067-2.

MLA (9th ed.) Citation

DM, Peereboom, et al. "Phase II Trial of Erlotinib with Temozolomide and Radiation in Patients with Newly Diagnosed Glioblastoma Multiforme." Journal of Neuro-oncology, vol. 98, no. 1, 2010, p. 93, https://doi.org/10.1007/s11060-009-0067-2.